Spruce Biosciences (SPRB) Shares Outstanding (Entity) (2019 - 2026)
Spruce Biosciences (SPRB) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 575.47 Mn |
| 10 | Spruce Biosciences | 122.59 Mn | 122.59 Mn | - | 2.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.87 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 766,598.00 |
| Sep 30, 2025 | 563,491.00 |
| Jun 30, 2025 | 563,042.00 |
| Mar 31, 2025 | 562,943.00 |
| Dec 31, 2024 | 562,943.00 |
| Sep 30, 2024 | 550,564.00 |
| Jun 30, 2024 | 550,564.00 |
| Mar 31, 2024 | 548,593.00 |
| Dec 31, 2023 | 546,928.00 |
| Sep 30, 2023 | 542,674.00 |
| Jun 30, 2023 | 542,674.00 |
| Mar 31, 2023 | 425,229.00 |
| Dec 31, 2022 | 314,601.00 |
| Sep 30, 2022 | 314,058.00 |
| Jun 30, 2022 | 314,058.00 |
| Mar 31, 2022 | 313,160.00 |
| Dec 31, 2021 | 313,147.00 |
| Sep 30, 2021 | 311,654.00 |